Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
synthetic cannabinoid
|
| gptkbp:actsOn |
CB1 receptor agonist
CB2 receptor agonist |
| gptkbp:affiliatedWith |
naphthoylindole family
|
| gptkbp:binding_affinity_for_CB1 |
1.2 nM
|
| gptkbp:binding_affinity_for_CB2 |
12.4 nM
|
| gptkbp:CASNumber |
324418-02-4
|
| gptkbp:chemicalFormula |
C25H23NO
|
| gptkbp:discoveredBy |
gptkb:John_W._Huffman
|
| gptkbp:firstSynthesized |
1990s
|
| https://www.w3.org/2000/01/rdf-schema#label |
JWH-081
|
| gptkbp:IUPACName |
4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone
|
| gptkbp:legal_status_in_UK |
Class B drug
|
| gptkbp:legalStatus |
Schedule I controlled substance
|
| gptkbp:molecularWeight |
353.46 g/mol
|
| gptkbp:namedAfter |
gptkb:John_W._Huffman
|
| gptkbp:psychoactive |
yes
|
| gptkbp:routeOfAdministration |
smoking
oral inhalation |
| gptkbp:used_in |
scientific research
|
| gptkbp:bfsParent |
gptkb:JWH_cannabinoids
|
| gptkbp:bfsLayer |
6
|